Comparative Effectiveness and Risk of Severe Infection in Adult Patients with Multiple Sclerosis Treated with Diroximel Fumarate Versus Anti-CD20 Monoclonal Antibodies: A Real-World Claims Analysis
MULTIPLE SCLEROSIS JOURNAL(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined